THERAPEUTISCHES DENDRIMER

European patent · EP4034169 · In force

Register entry

Publication number
EP4034169
Application number
EP20869915
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 25, 2020
Published
Aug 3, 2022
Granted
Feb 11, 2026
Protection ends at the latest
Sep 24, 2040
Next annual fee due
Sep 30, 2026
IPC classes
A61K 47/64 (2017.01)
A61K 31/7072 (2006.01)
A61K 31/337 (2006.01)
C08G 69/10 (2006.01)
C08G 83/00 (2006.01)
A61K 49/12 (2006.01)
A61P 35/00 (2006.01)
A61K 9/48 (2006.01)
A61K 31/282 (2006.01)
A61K 31/555 (2006.01)
A61K 31/7068 (2006.01)
A61K 45/06 (2006.01)
A61P 1/18 (2006.01)
C08G 69/48 (2006.01)
A61K 47/60 (2017.01)
Priority
AU 2019903628 26.09.2019
AU 2019904094 30.10.2019
PCT application
PCT/AU2020/051028 25.09.2020
PCT publication
WO2021/056077 01.04.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 11, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.02.2026

Parties

Holder

Starpharma Pty Limited

4/6 Southampton Crescent, Abbotsford VIC 3067, AU

Inventor

OWEN, David James

Preston, VIC 3072, AU

PATHAK, Rashmi

Preston, VIC 3072, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.